Table 2.

Treatment efficacy in patients with and without HTN

Clinical outcomes	All (n=110)	Normotensive (n=64)	Hypertensive (n=46)	P-value
Response rate				0.002
PR	18	4	14
SD	55	31	24
PD	37	29	8
PFS (months)	4.6	4.2	5.6	0.0027
OS (months)	8.2	7.8	9.9	0.005

Abbreviations: HTN, hypertension; PR, partial response; SD, stable disease; PD, progressive disease; PFS, progression-free survival; OS, overall survival.